Paul Jorgensen

Paul Jorgensen

ID: 1b839954-2619-30fb-68c4

/

Claimed Record

/

Organization: Norton Rose Fulbright

CADTH advisory panel consults on framework for pan-Canadian formulary

Pharma in Brief · February 2, 2022

Federal Court of Appeal provides guidance on the “inventive concept”

Pharma in Brief · March 23, 2021

Federal Court finds 45-day limitation period does not apply to s 8.2 PM(NOC) related rights of action for unlisted patents

Pharma in Brief · March 2, 2021

Federal Court of Appeal Upholds First Trial Judgment under New PM(NOC) Regulations

Pharma in Brief · November 18, 2020

Two PM(NOC) Actions Dismissed After Common Trial on Validity of Treatment Regimen Patent

Pharma in Brief · June 1, 2020

Practice Areas

Health Care and Life Sciences

Jurisdictions